Clinical Trial Results: Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor

View source ↗

Summary

A completed clinical trial evaluating reticulocyte hemoglobin content (RET-he) in the management of functional anemia in adults with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Solid Tumors

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Solid Tumor, Adult, Anemia Deficiency | Status: COMPLETED | Results posted: 2026-08-17